Funding News - NINDS Seeks Persons with Parkinson’s Disease

Skip secondary menu

Scientists at the National Institute of Neurological Disorders and Stroke (NINDS) seek persons with Parkinson's disease for a research study. In the study, investigators plan to use a device to see if stimulation of certain areas of the brain, along with the patient's current medications, will improve movement, balance, and walking. The study will last approximately 4 weeks and include eight stimulation sessions. Each session will last approximately 1 hour.

Eligible participants must be 40 to 80 years of age and be taking an L-DOPA medication such as Sinemet. Persons who have metal implants in their body, other significant medical or psychiatric illness, or a history of seizures are not eligible.

The studies will take place at the National Institutes of Health (NIH) Clinical Center in Bethesda, MD. Compensation is provided to all participants. There is no cost for participation or for any tests associated with the research. All study-related expenses will be paid by the NIH. This study is conducted under safety and testing standards of the Department of Health and Human Services.

For more information on protocol #03-N-0116, with no obligation to participate, please contact Dr. Mikhail Lomarev, NINDS, NIH, Building 10, Room 5N240, 10 Center Drive MSC 1428, Bethesda, MD 20892-1428; telephone: 301-594-0937 or 301-435-8518; fax: 301-480-2286; e-mail: LomarevM@ninds.nih.gov.


This content has been adapted from the original NINDS Notes publication. For the most up-to-date funding information, please visit the Funding Opportunities section of the NINDS web site.  For the most recent information on NINDS studies, please visit the NINDS Patient Recruitment web site.